Association of psychiatric manifestations with antibodies to ribosomal p proteins in systemic lupus erythematosus☆

https://doi.org/10.1016/0002-9343(91)90506-SGet rights and content

Abstract

purpose: The goal of this study was to determine whether elevated serum levels of antibodies to ribosomal P proteins (anti-P antibodies) are associated with neuropsychiatric manifestations in patients with systemic lupus erythematosus (SLE). Additional experiments examined characteristics of these antibodies that might be associated with pathogenicity.

patients and methods: A large number of serum samples were collected from patients with SLE, control subjects with other rheumatic diseases, and normal individuals. At the time serum samples were obtained, patients with SLE were categorized according to the presence of psychosis, depression, and other manifestations of central nervous system (CNS) involvement. Serum anti-P antibody activity was quantitated by an enzyme-linked immunosorbent assay utilizing a synthetic peptide corresponding to the major P protein epitope.

results: In a group of 79 normal individuals, mean (± SE) IgG anti-P activity was 0.01 ± 0.003 and no individuals had values greater than 3 SD above the mean. Similar results were obtained measuring IgM anti-P activity. Normal levels were found in all sera from 21 patients with rheumatoid arthritis. Of 119 patients demonstrating various patterns of antinuclear and anticytoplasmic antibody activity, elevated anti-P levels were found only in patients with SLE. Overall, 19% of 269 patients with SLE demonstrated elevated levels of IgG or IgM anti-P antibodies, including 14% of 187 patients without and 29% of 82 patients with neuropsychiatric manifestations. The frequency of positive test results varied greatly depending on the nature of the CNS involvement. The frequency in patients with severe depression (n = 8) and psychosis (n = 29) was 88% and 45%, respectively, compared with only 9% in patients with nonpsychiatric neurologic disease (n = 45). For the entire SLE group, the odds ratio for the association of anti-P antibodies and severe psychiatric manifestations was 7.63 with a 95% confidence interval of 3.61 to 16.14. In a review of 187 patients with SLE originally classified as not having severe psychiatric disease, seven of 10 patients being treated with antidepressant medications had elevated levels of anti-P antibodies. In serial studies, the serum level of anti-P antibodies appeared to correlate with the activity of psychiatric disease and did not correlate with the activity of other manifestations of SLE. Anti-P antibodies in nearly all patients were IgG and directed primarily to the C-terminal 11 amino acids of the P protein. No difference in these characteristics was observed when patients with and without psychiatric manifestations were compared. Paired serum and cerebrospinal fluid (CSF) samples were also obtained from eight patients with active neuropsychiatric disease. Even when expressed as a fraction of the total IgG present, anti-P activity was markedly lower in CSF than in serum.

conclusions: Elevated levels of autoantibodies to the C-terminal region of ribosomal P proteins appear to be a specific marker for SLE, and are associated with both severe depression and psychosis in this disease. This assay is easily reproducible and may help distinguish SLE-induced psychiatric disease from that caused by other processes.

References (27)

  • HA Wilson et al.

    Association of IgG anti-brain antibodies with central nervous system dysfunction in systemic lupus erythematosus

    Arthritis Rheum

    (1979)
  • A How et al.

    Antineuronal antibodies in neuropsychiatric systemic lupus erythematosus

    Arthritis Rheum

    (1985)
  • GL Asherson

    Antibodies against nuclear and cytoplasmic cell constituents in systemic lupus erythematosus and other diseases

    Br J Exp Pathol

    (1960)

    • Cited by (241)

    • Tissue resident cell processes determine organ damage in systemic lupus erythematosus

      2022, Clinical Immunology

    • The immunologic etiology of psychiatric manifestations in systemic lupus erythematosus: A narrative review on the role of the blood brain barrier, antibodies, cytokines and chemokines

      2020, Autoimmunity Reviews
      Citation Excerpt :

      However, more convincing evidence concerning the association between anti-RP in serum/CSF, depression and psychosis suggests a role for anti-RP in the pathogenesis of these NPSLE manifestations by mediating concentration dependent neuronal dysfunction or apoptosis. Several studies demonstrated a correlation between anti-RP in serum or CSF, psychiatric NPSLE [18,23,80,102,113,118,122,23,138,151] and more specifically depression [23,80,120,124–126] and lupus psychosis [80–82,109,119–121,124–135,152]. An important number of studies (N=20) could not confirm the association between anti-RP in serum or CSF and psychiatric NPSLE as a group [81,82,96,98,111,112,115,132,134,137,139–147,151], though considerably fewer studies disputed the association between serum anti-RP, depression [110,148–150] and psychosis [113,136,149,150].

    • The Bidirectional Relationship of Depression and Inflammation: Double Trouble

      2020, Neuron
      Citation Excerpt :

      Thus, a high titer of anti-phospholipid antibodies was found in 63 depressed patients compared to healthy controls (Gorman and Cummings, 1993; Maes et al., 1993). In addition, the presence of anti-ribosomal-P antibodies has been associated with depression and psychosis in patients with lupus erythematosus (Nojima et al., 1992; Schneebaum et al., 1991; Tzioufas et al., 2000; Watanabe et al., 1996). Furthermore, CSF anti-N-methyl-D-aspartate receptor NR2 antibodies are elevated in systemic lupus erythematosus patients with active neuropsychiatric manifestations, and these are associated with BBB damage (Hirohata et al., 2014), whereas only the serum level of anti-Sm antibodies but not serum levels of anti-NR2, anti-P, or anti-phospholipid antibodies contributes to the BBB disruption in these patients (Hirohata et al., 2018).

    • The diagnosis and clinical management of the neuropsychiatric manifestations of lupus

      2016, Journal of Autoimmunity
      Citation Excerpt :

      see Table 5: Association between Abs and specific neuropsychiatric syndromes). Compared with SLE patients, NPSLE patients are more likely to have elevated serum levels of LA, APL, aCL [23,27,37,63,70,84,84,89,136,136,172,179–185], anti-Rib-P Abs [63,136,141–144,146,149,150,153,172,179,180,184,186–189] and increased CSF levels of anti-neuronal Abs [136,184,190–194]. Table 5 summarizes the common association between NPSLE clinical pictures and single Abs positivity or combined Abs positivity.

    • A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus

      2016, Autoimmunity Reviews

    • The importance of cytokines and autoantibodies in depression

      2015, Autoimmunity Reviews
    View all citing articles on Scopus
    ☆

    This work was supported in part by Grants AR 37070 and AI-28495 from the National Institutes of Health.

    1

    Dr. Schneebaum's current address: Division of Rheumatology, Lahey Clinic Medical Center, 41 Mall Road, Burlington, Massachusetts 01805.

    View full text
    Copyright © 1991 Published by Excerpta Medica Inc.